Survey Reveals Clinician Fears Remain Unallayed
London – 4 September, 2013 – Less than a third of doctors, nurses and surgeons in the cosmetic surgery arena believe that the recommendations from Sir Bruce Keogh’s recent review into the sector go far enough, and three quarters (75%) think there could still be a repeat of a health scandal such as the recent breast implant crisis. The findings are unveiled today by Clinical Cosmetic & Reconstructive Expo (www.ccr-expo.com), a first-of-its kind event taking place this October at London, Olympia bringing together under one roof the foremost experts in aesthetic, reconstructive and non-surgical treatment.
previous poll by CCR revealed that the vast majority of medical professionals felt
that ‘plastic’ and ‘cosmetic’ surgery had become interchangeable terms in the
public’s mind thereby endangering patients. Today’s follow-up results show that
clinicians lay the blame squarely on the lack of Government regulation,
unethical marketing by practitioners themselves and irresponsible reporting by
the media for the situation. They feel advertising needs to be strictly controlled,
and the practice of using airbrushed models instead of real patients banned
According to consultant plastic surgeon and Chairman of the Expo’s Medical Advisory Board Norman Waterhouse, a former Head of the Craniofacial Unit at Chelsea and Westminster Hospital and also former President of the British Association of Aesthetic Plastic Surgeons (BAAPS);“Bruce Keogh’s recently published review is not the first Government report on safety and regulation in aesthetic surgery. In the past recommendations of reviews have been largely ignored and if one were cynical many clinicians feel that this recent review has been fast tracked as a result of the implant scandal - and are not holding their breath in terms of expecting concrete measures for implementation of the recommendations. Perhaps however, there is now a greater appetite for change and the PIP issue and concerns around injectables will stimulate some real progress. For all those engaged in aesthetic practice we have a collective responsibility to maintain and improve standards. This conference offers an excellent platform for helping to influence the future direction of our profession.”
Survey highlights:Top three reasons (in order of preference) why there has been a blurring of lines between beauty treatments and ‘serious’ surgery:
1) Lack of statutory controls/regulation and definition of who can perform what procedures
2) Unethical marketing by clinics and practitioners
3) Irresponsible reporting by the media
Three quarters (75%) of clinicians feel there could be a repeat of the PIP implant crisis - only 7% answered ‘no’!
When asked whether the recommendations from Sir Bruce Keogh’s review into cosmetic surgery ‘went far enough’, over half (55%) said they ‘didn’t know’ - only 28% said ‘yes'.
Defining what could be considered ‘acceptable’ or ethical marketing, over two thirds (67%) agreed that whilst advertising didn’t need to be banned outright, it should be strictly controlled. Well over half (55%) of respondents agreed that special offers, discounts and ‘BOGOFs’ should be prohibited, and that images used in promotions should only be of real patients rather than airbrushed models.
Despite Sir Bruce Keogh’s recommendation of ‘proper training’ for anyone performing non-surgical procedures such as facial injectables, nine out of ten (88%) of clinicians remain steadfast in their view that any such qualifications must only be made available to medical professionals.
Running alongside the three individual conferences (reconstructive, aesthetic and non-surgical) taking place simultaneously during the event, will be a series of live debates on the key issues of the industry. Expert panels will lead and invite discussion on a wide variety of themes; from cultural standards of beauty, the PIP implant scandal, new EU regulations and the implications of the Keogh review to what is ethical marketing, as well as what appropriate training for injectables should entail.
According to Peter Jones, Chief Executive Officer for CCR Expo;
“We have carefully designed and structured a specialised meeting agenda packing 14 days’ worth of workshops, seminars, live demonstrations and debates specifically around the goals of sharing advances, and fostering innovation in the plastic surgery and non-surgical sector. From Botox to bionic limbs, we are creating a new and inclusive environment that encourages dialogue and continuous improvement which will ultimately benefit patients all around the UK.”
ENDSAbout Clinical Cosmetic & Reconstructive (CCR) Expo
Clinical Cosmetic & Reconstructive (CCR) Expo is a groundbreaking business-to-business event that will bring the international surgical and non-surgical community together under one roof. The expo runs from 11-12 October 2013 at London, Olympia and will showcase over 120 international exhibitors: from cutting edge surgical equipment and supplies through to non-invasive products, business services, training and consultancy. There will be 14 days of Continuing Professional Development (CPD) content, including workshops, conferences and live demonstration theatres, packed into an exciting two-day event. Clinical Cosmetic & Reconstructive Expo is organised by NINETEEN EVENTS, whose management team has a solid track record of organising large-scale international award winning shows. To visit the CCR expo website please go to www.ccr-expo.com and to follow on twitter @ccr_expo. To visit NINETEEN EVENTS please go to www.nineteen-events.com
For press and media enquiries please contact the Press Office on 020 7549 2863 / firstname.lastname@example.org